Compare $BIAF vs $CDIO | Chartloom

Compare

$BIAF vs $CDIO

bioAffinity Technologies Inc · Cardio Diagnostics Holdings Inc

BIAF

bioAffinity Technologies Inc

CDIO

Cardio Diagnostics Holdings Inc

Compare $BIAF vs $CDIO

Comparing bioAffinity Technologies Inc and Cardio Diagnostics Holdings Inc

BIAFbioAffinity Technologies Inc

CDIOCardio Diagnostics Holdings Inc

BIAFbioAffinity Technologies Inc

Market cap

$37M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-23.2%

YTD performance

-74.2%

52W performance

-89.7%

FCF yield

-31.5%

CDIOCardio Diagnostics Holdings Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-25.1%

YTD performance

-34.2%

52W performance

-58.8%

FCF yield

-110.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIAF

CDIO

Detailed metrics comparison

BIAF

bioAffinity Technologies Inc

CDIO

Cardio Diagnostics Holdings Inc

Market Cap

BIAF$37M

CDIO$6M

Enterprise Value

BIAF$35M

CDIO$16K

Price

BIAF$4.73

CDIO$1.87

P/E Ratio

BIAFN/A

CDION/A

P/S Ratio

BIAF6.23x

CDIO379.12x

EV/Sales

BIAF5.93x

CDIO1.10x

EV/EBITDA

BIAF0.00x

CDIO0.00x

P/B Ratio

BIAF1.87x

CDIO0.78x

P/FCF Ratio

BIAFN/A

CDION/A

EV/FCF

BIAF-3.02x

CDIO-0.00x

PEG Ratio

BIAFN/A

CDION/A

Forward P/E (NTM)

BIAFN/A

CDION/A

Forward P/S (NTM)

BIAFN/A

CDION/A

Revenue (TTM)

BIAF$6M

CDIO$15K

Revenue Growth (YoY)

BIAF-23.2%

CDIO-25.1%

Forward Rev Growth

BIAF0.0%

CDIO0.0%

Gross Margin (TTM)

BIAF34.6%

CDIO0.0%

Operating Margin (TTM)

BIAF0.0%

CDIO0.0%

EBITDA Margin (TTM)

BIAF-202.8%

CDIO-41671.2%

Net Margin (TTM)

BIAF-257.3%

CDIO-44312.3%

FCF Margin (TTM)

BIAF-196.0%

CDIO-41825.3%

Net Income (TTM)

BIAF$-15M

CDIO$-6M

FCF (TTM)

BIAF$-12M

CDIO$-6M

EPS (TTM)

BIAF-$43.57

CDIO-$2.19

ROE (TTM)

BIAF-25727.0%

CDIO-8227.0%

ROA (TTM)

BIAF-15954.0%

CDIO-7602.0%

ROIC (TTM)

BIAF-23305.0%

CDIO-8097.0%

Cash

BIAF$2M

CDIO$6M

Debt

BIAF$634K

CDIO$68K

Net Cash/Debt

BIAF$2M

CDIO$6M

Current Ratio (TTM)

BIAF1.44x

CDIO17.15x

Quick Ratio (TTM)

BIAF1.36x

CDIO15.56x

Debt/Equity (TTM)

BIAF0.17x

CDIO0.01x

Debt/Assets (TTM)

BIAF0.0%

CDIO0.0%

Interest Coverage (TTM)

BIAFN/A

CDION/A

Net Debt/EBITDA (TTM)

BIAF0.00x

CDIO0.00x

Beta

BIAF-1.26

CDIO2.30

52W Performance

BIAF-89.7%

CDIO-58.8%

YTD Performance

BIAF-74.2%

CDIO-34.2%

% from 52W High

BIAF-94.1%

CDIO-76.4%

% from 52W Low

BIAF3.6%

CDIO92.8%

Asset Turnover (TTM)

BIAF0.62x

CDIO0.00x

FCF Yield (TTM)

BIAF-31.5%

CDIO-110.3%

Earnings Yield (TTM)

BIAF-41.3%

CDIO-116.9%

Dividend Yield (TTM)

BIAFN/A

CDION/A

Rule of 40

BIAF-219.2

CDIO-41,850.5

EV/GP/RG

BIAFN/A

CDION/A

Ticker research

View BIAF research View CDIO research

Metric	BIAF bioAffinity Technologies Inc	CDIO Cardio Diagnostics Holdings Inc
Market & Valuation
Market Cap	$37M	$6M
Enterprise Value	$35M	$16K
Price	$4.73	$1.87
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	379.12x
EV/Sales	5.93x	1.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	0.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$15K
Revenue Growth (YoY)	-23.2%	-25.1%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	34.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-202.8%	-41671.2%
Net Margin (TTM)	-257.3%	-44312.3%
FCF Margin (TTM)	-196.0%	-41825.3%
Net Income (TTM)	$-15M	$-6M
FCF (TTM)	$-12M	$-6M
EPS (TTM)	-$43.57	-$2.19
ROE (TTM)	-25727.0%	-8227.0%
ROA (TTM)	-15954.0%	-7602.0%
ROIC (TTM)	-23305.0%	-8097.0%
Financial Health
Cash	$2M	$6M
Debt	$634K	$68K
Net Cash/Debt	$2M	$6M
Current Ratio (TTM)	1.44x	17.15x
Quick Ratio (TTM)	1.36x	15.56x
Debt/Equity (TTM)	0.17x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.26	2.30
52W Performance	-89.7%	-58.8%
YTD Performance	-74.2%	-34.2%
% from 52W High	-94.1%	-76.4%
% from 52W Low	3.6%	92.8%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	-31.5%	-110.3%
Earnings Yield (TTM)	-41.3%	-116.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-219.2	-41,850.5
EV/GP/RG	N/A	N/A
Ticker research	View BIAF research	View CDIO research

Valuation

P/S Ratio

BIAF

6.23x

CDIO

379.12x

EV/FCF

BIAF

-3.02x

CDIO

-0.00x

Growth & revenue

Revenue Growth TTM

BIAF

-23.2%

CDIO

-25.1%

Forward Revenue Growth

BIAF

0.0%

CDIO

0.0%

Profitability & performance

Gross Margin

BIAF

34.6%

CDIO

0.0%

ROE

CDIO

-8227.0%

BIAF

-25727.0%

FCF Yield %

BIAF

-31.5%

CDIO

-110.3%

52-Week Performance

CDIO

-58.8%

BIAF

-89.7%

Detailed metrics comparison

BIAF

bioAffinity Technologies Inc

CDIO

Cardio Diagnostics Holdings Inc

Market Cap

BIAF$37M

CDIO$6M

Enterprise Value

BIAF$35M

CDIO$16K

Price

BIAF$4.73

CDIO$1.87

P/E Ratio

BIAFN/A

CDION/A

P/S Ratio

BIAF6.23x

CDIO379.12x

EV/Sales

BIAF5.93x

CDIO1.10x

EV/EBITDA

BIAF0.00x

CDIO0.00x

P/B Ratio

BIAF1.87x

CDIO0.78x

P/FCF Ratio

BIAFN/A

CDION/A

EV/FCF

BIAF-3.02x

CDIO-0.00x

PEG Ratio

BIAFN/A

CDION/A

Forward P/E (NTM)

BIAFN/A

CDION/A

Forward P/S (NTM)

BIAFN/A

CDION/A

Revenue (TTM)

BIAF$6M

CDIO$15K

Revenue Growth (YoY)

BIAF-23.2%

CDIO-25.1%

Forward Rev Growth

BIAF0.0%

CDIO0.0%

Gross Margin (TTM)

BIAF34.6%

CDIO0.0%

Operating Margin (TTM)

BIAF0.0%

CDIO0.0%

EBITDA Margin (TTM)

BIAF-202.8%

CDIO-41671.2%

Net Margin (TTM)

BIAF-257.3%

CDIO-44312.3%

FCF Margin (TTM)

BIAF-196.0%

CDIO-41825.3%

Net Income (TTM)

BIAF$-15M

CDIO$-6M

FCF (TTM)

BIAF$-12M

CDIO$-6M

EPS (TTM)

BIAF-$43.57

CDIO-$2.19

ROE (TTM)

BIAF-25727.0%

CDIO-8227.0%

ROA (TTM)

BIAF-15954.0%

CDIO-7602.0%

ROIC (TTM)

BIAF-23305.0%

CDIO-8097.0%

Cash

BIAF$2M

CDIO$6M

Debt

BIAF$634K

CDIO$68K

Net Cash/Debt

BIAF$2M

CDIO$6M

Current Ratio (TTM)

BIAF1.44x

CDIO17.15x

Quick Ratio (TTM)

BIAF1.36x

CDIO15.56x

Debt/Equity (TTM)

BIAF0.17x

CDIO0.01x

Debt/Assets (TTM)

BIAF0.0%

CDIO0.0%

Interest Coverage (TTM)

BIAFN/A

CDION/A

Net Debt/EBITDA (TTM)

BIAF0.00x

CDIO0.00x

Beta

BIAF-1.26

CDIO2.30

52W Performance

BIAF-89.7%

CDIO-58.8%

YTD Performance

BIAF-74.2%

CDIO-34.2%

% from 52W High

BIAF-94.1%

CDIO-76.4%

% from 52W Low

BIAF3.6%

CDIO92.8%

Asset Turnover (TTM)

BIAF0.62x

CDIO0.00x

FCF Yield (TTM)

BIAF-31.5%

CDIO-110.3%

Earnings Yield (TTM)

BIAF-41.3%

CDIO-116.9%

Dividend Yield (TTM)

BIAFN/A

CDION/A

Rule of 40

BIAF-219.2

CDIO-41,850.5

EV/GP/RG

BIAFN/A

CDION/A

Ticker research

View BIAF research View CDIO research

Metric	BIAF bioAffinity Technologies Inc	CDIO Cardio Diagnostics Holdings Inc
Market & Valuation
Market Cap	$37M	$6M
Enterprise Value	$35M	$16K
Price	$4.73	$1.87
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	379.12x
EV/Sales	5.93x	1.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	0.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	-0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$15K
Revenue Growth (YoY)	-23.2%	-25.1%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	34.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-202.8%	-41671.2%
Net Margin (TTM)	-257.3%	-44312.3%
FCF Margin (TTM)	-196.0%	-41825.3%
Net Income (TTM)	$-15M	$-6M
FCF (TTM)	$-12M	$-6M
EPS (TTM)	-$43.57	-$2.19
ROE (TTM)	-25727.0%	-8227.0%
ROA (TTM)	-15954.0%	-7602.0%
ROIC (TTM)	-23305.0%	-8097.0%
Financial Health
Cash	$2M	$6M
Debt	$634K	$68K
Net Cash/Debt	$2M	$6M
Current Ratio (TTM)	1.44x	17.15x
Quick Ratio (TTM)	1.36x	15.56x
Debt/Equity (TTM)	0.17x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.26	2.30
52W Performance	-89.7%	-58.8%
YTD Performance	-74.2%	-34.2%
% from 52W High	-94.1%	-76.4%
% from 52W Low	3.6%	92.8%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	-31.5%	-110.3%
Earnings Yield (TTM)	-41.3%	-116.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-219.2	-41,850.5
EV/GP/RG	N/A	N/A
Ticker research	View BIAF research	View CDIO research